Latest news with #shareholderRights
Globe and Mail
09-07-2025
- Business
- Globe and Mail
VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Verona Pharma plc (NASDAQ: VRNA) to Merck for $107.00 per American Depository Share is fair to Verona shareholders. Halper Sadeh encourages Verona shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@ or zhalper@ The investigation concerns whether Verona and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Verona shareholders; (2) determine whether Merck is underpaying for Verona; and (3) disclose all material information necessary for Verona shareholders to adequately assess and value the merger consideration. On behalf of Verona shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Associated Press
09-07-2025
- Business
- Associated Press
VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Jul 9, 2025-- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Verona Pharma plc (NASDAQ: VRNA) to Merck for $107.00 per American Depository Share is fair to Verona shareholders. Halper Sadeh encourages Verona shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether Verona and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Verona shareholders; (2) determine whether Merck is underpaying for Verona; and (3) disclose all material information necessary for Verona shareholders to adequately assess and value the merger consideration. On behalf of Verona shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. View source version on CONTACT: Halper Sadeh LLC One World Trade Center 85th Floor New York, NY 10007 Daniel Sadeh, Esq. Zachary Halper, Esq. (212) 763-0060 [email protected] [email protected] KEYWORD: UNITED STATES NORTH AMERICA NEW YORK INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: Halper Sadeh LLC Copyright Business Wire 2025. PUB: 07/09/2025 12:07 PM/DISC: 07/09/2025 12:07 PM
Globe and Mail
08-07-2025
- Business
- Globe and Mail
PBBK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of PB Bankshares, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of PB Bankshares, Inc. (NASDAQ: PBBK) to Norwood Financial Corp is fair to PB Bankshares shareholders. Under the terms of the proposed transaction, PB Bankshares' shareholders will have the option to elect to receive either 0.7850 shares of Norwood common stock or $19.75 in cash for each common share of PB Bankshares they own. The election is subject to proration to ensure that, in the aggregate, 80% of the transaction consideration will be paid in the form of Norwood common stock. Halper Sadeh encourages PB Bankshares shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@ or zhalper@ The investigation concerns whether PB Bankshares and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for PB Bankshares shareholders; (2) determine whether Norwood is underpaying for PB Bankshares; and (3) disclose all material information necessary for PB Bankshares shareholders to adequately assess and value the merger consideration. On behalf of PB Bankshares shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
Yahoo
16-06-2025
- Business
- Yahoo
Victoria's Secret faces fresh activist fight from Barington Capital, source says
By Abigail Summerville NEW YORK (Reuters) -Activist investor Barington Capital Group plans to mount a push to change Victoria's Secret's board of directors and end a recently adopted shareholder's rights plan, according to a person familiar with the situation. The New York-based hedge fund, which owns more than 1% of the company, believes Victoria's Secret has underperformed its competitors and lost value since its spin-off from former parent company L Brands in 2021, the person said, asking not to be identified because the matter is private. Amid waning demand for its intimate apparel, Victoria's Secret shares have dropped by about 55% this year, and its current market value is about $1.45 billion. The Wall Street Journal reported Barington's plans earlier on Sunday. A Victoria's Secret spokesperson said that Barington has not contacted the company, but it looks forward to "discussing their views with them." "We are confident that executing our strategy under the new and experienced leadership team will continue to unlock value for our shareholders," the spokesperson said. Barington wants the company to replace most or all of its board and end the "poison pill" plan that it adopted in May to protect it from hostile takeovers. It also believes the retailer should focus on core brands and initiatives, like bras and the Angels campaign, and accelerate growth in digital and international markets, the source said. Barington believes the company's Chief Executive Hillary Super, who took over in September 2024, has limited public company experience, and that the rest of the board lacks the necessary experience to revitalize the iconic brand, the person said. Super was previously the CEO of intimates brand Savage X Fenty. The fund also sees value in the Victoria's Secret beauty business, which it believes could be worth as much as the company's market value. Victoria's Secret adopted the poison pill plan to fend off investment firm BBRC International Private Limited, which increased its stake in the company to around 13%. Barington is also an investor in Macy's and Hanesbrands. Founded by James Mitarotonda, Barington previously pushed for changes at L Brands, which split into Victoria's Secret and Bath & Body Works. At Macy's, the firm wanted the department store to create a real estate unit and cut costs to boost the share price. Earlier this year, Barington mounted its first full-blown board room challenge since 2015 when it tried to put three directors on the board of casket maker Matthews International but ended up losing the vote.
Reuters
16-06-2025
- Business
- Reuters
Victoria's Secret faces fresh activist fight from Barington Capital, source says
NEW YORK, June 15 (Reuters) - Activist investor Barington Capital Group plans to mount a push to change Victoria's Secret's (VSCO.N), opens new tab board of directors and end a recently adopted shareholder's rights plan, according to a person familiar with the situation. The New York-based hedge fund, which owns more than 1% of the company, believes Victoria's Secret has underperformed its competitors and lost value since its spin-off from former parent company L Brands in 2021, the person said, asking not to be identified because the matter is private. Amid waning demand for its intimate apparel, Victoria's Secret shares have dropped by about 55% this year, and its current market value is about $1.45 billion. The Wall Street Journal reported Barington's plans earlier on Sunday. A Victoria's Secret spokesperson said that Barington has not contacted the company, but it looks forward to "discussing their views with them." "We are confident that executing our strategy under the new and experienced leadership team will continue to unlock value for our shareholders," the spokesperson said. Barington wants the company to replace most or all of its board and end the "poison pill" plan that it adopted in May to protect it from hostile takeovers. It also believes the retailer should focus on core brands and initiatives, like bras and the Angels campaign, and accelerate growth in digital and international markets, the source said. Barington believes the company's Chief Executive Hillary Super, who took over in September 2024, has limited public company experience, and that the rest of the board lacks the necessary experience to revitalize the iconic brand, the person said. Super was previously the CEO of intimates brand Savage X Fenty. The fund also sees value in the Victoria's Secret beauty business, which it believes could be worth as much as the company's market value. Victoria's Secret adopted the poison pill plan to fend off investment firm BBRC International Private Limited, which increased its stake in the company to around 13%. Barington is also an investor in Macy's and Hanesbrands. Founded by James Mitarotonda, Barington previously pushed for changes at L Brands, which split into Victoria's Secret and Bath & Body Works. At Macy's, the firm wanted the department store to create a real estate unit and cut costs to boost the share price. Earlier this year, Barington mounted its first full-blown board room challenge since 2015 when it tried to put three directors on the board of casket maker Matthews International but ended up losing the vote.
